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Abstract
This chapter presents factors or considerations to be taken into account when selecting
the procedure or method for obtaining extracts and bioactive compounds. The genus
Taraxacum has proved to have several interesting properties and there are numerous
techniques and bioassays used to test the antimicrobial properties of extracts. However,
the extraction process is crucial to optimize the final biological outcomes. Extraction
procedures that until now have been used are simple and inexpensive, however, we
wanted to report a series of studies that group valuable results, which could be useful
for future studies, enhancing the research carried out by authors from all over the world
and also allowing the interrelated study of this genus.
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1. Introduction
Taraxacum has been worldwide tested against several bacterial and fungal strains under vari-
ous extract conditions and bioassays, and we compiled enough published information with
the aim of comparing and/or relationship between the various existing methods and their
result in the antimicrobial profile.
1.1. Antimicrobial bioassay methods used in Taraxacum genus
Several different methods have been used for testing antimicrobial activity, the application of
which most often depends on the available instrumentation and the training of the investiga-
tors [1]. Screening for antibacterial and antifungal activity is often done by agar disc diffusion,
agar well test diffusion, and agar dilution or microdilution broth. In agar disc diffusion, a
paper disc soaked with the extract is laid on top of an inoculated agar plate and is generally
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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Strains Bioassay Results expresion Positive control Active concentration Main results Reference
Alternaria alternata Broth dilution assay IC50, MIC,
Morphological
changes
None 15 μM 2.9 μM; 1.0 μM; + [5]
A. alternata Paper disc diffusion method % Inhibition None S, S/2, S/10, S/100 16.7–76.2% [6]
A. carbonarius (Bainier)
Thom
Microassay method on
slides
ICG, IGTE Only in vivo assays (Imazalil,
Fenhexamid)
0.75X 4%, 0% [7]
A. flavus 0064 Agar tube dilution Inhibition growth Terbinafine 12 mg/mL 100% 15 mg/mL 70.80% [8]
A. fumigatus 66 Agar tube dilution Inhibition growth Terbinafine 12 mg/mL 100% 16 mg/mL 84.80% [8]
A. hidrophila (food
poisoning patients)
Agar diffusion method Inhibition zone Cephalotin 30 μg/mL (20 mm) 10 mg/mL No activity [9]
A. niger Broth dilution assay IC50, MIC,
Morphological
changes
None 15 μM 4.2 μM; 2.8 μM; + [5]
A. niger 0198 Agar tube dilution Inhibition growth Terbinafine 12 mg/mL 100% 17 mg/mL 37.40% [8]
A. niger UPCC 3701 Agar well diffusion Inhibition zone,
antimicotic index
Canesten (23 mm, 1.3) 30 μg No activity [9]
A. niger van Thiegem Microassay method on
slides
ICG, IGTE Only in vivo assays (Imazalil,
Fenhexamid)
0.75X 3%, 45% [7]
A. niger VKM F-33 Broth dilution assay IC50 (50% growth
inhibition)
None 6–10 μM 1.2–5.6 μM [10]
A. niger VKM F-33 Microtiterd method IC50 None 15.6–250 μg/mL No activity [11]
A. flavus QC 6658 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
A. fumigatus Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
A. niger Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
B. cereus Agar diffusion method Inhibition zone Cephalotin 30 μg/mL (22 mm) 10 mg/mL 18 mm [9]
B. cereus (spoiled rice) Agar diffusion method Inhibition zone Cephalotin 30 μg/mL (20 mm) 10 mg/mL 18 mm [9]
B. cereus ATCC 1778 Broth dilution assay MIC Cloramphenicol (0.004 μM) No information 2.5 μM [13]
B. cereus NCTC 7464 Broth dilution assay MIC None 2 mg/mL 500 μg/mL [14]
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B. cereus NCTC 7464 Microtiterd method MIC None 2 mg/mL 250 μg/mL [15]
B. cinérea Microassay method on
slides
ICG, IGTE Only in vivo assays (Imazalil,
Fenhexamid)
0.75X 9%, 38% [7]
B. cinerea SGR-1 Broth dilution assay IC50 (50% growth
inhibition)
None 6–10 μM 5.2–5.8 μM [5]
B. cinerea SGR-1 Microtiterd method IC51 None 15.6–250 μg/mL No activity [11]
B. sorokiniana Broth dilution assay IC50, MIC,
Morphological
changes
None 15 μM >15 μM; >15 μM; [10]
B. sorokiniana 6/10 Broth dilution assay IC50 (50% growth
inhibition)
None 6–10 μM 5.2 μM [5]
B. sorokiniana F-1446 Microtiterd method IC52 None 15.6–250 μg/mL No activity [10, 11]
B. subtilis Agar diffusion method Inhibition zone Gentamicyn 1 mg/disc,
Tetracyclin 2 mg/disc
4–12 μg/disc weak activity, not
indicated
[16]
B. subtilis Agar inoculation MIC None No information 7.0 mg/mL [17]
B. subtilis Disc diffusion method Inhibition zone None No information 12.04 mm [18]
B. subtilis Disc diffusion method Inhibition zone Tetracyclin 10 μg/disc
(23.6 mm)
10 mg/mL 5.1–97.9% [19]
B. subtilis Broth dilution MIC Tetracyclin (MIC 5.0 μg/mL) 10 μg/mL 5.1–97.9% [19]
B. subtilis Agar well diffusion Inhibition zone None 120 μg/mL 10.0–14.0 mm [20]
B. subtilis Broth dilution assay MIC Tetracyclin 100 μg/mL (84%) 50 mg/mL 10–54% [4]
B. subtilis Disc diffusion method Inhibition zone Tetracyclin 100 μg/mL
(22 mm)
50 mg/mL 11–19 mm [4]
B. subtilis ATCC 1149 Agar well diffusion Inhibition zone,
antimicotic index
Chloramphenicol (8 mm, 0.3) 30 μg 11 mm, 0.1 [9]
B. subtilis ATCC 6633 Agar diffusion method Inhibition zone, MIC Erythromicin 1.0 μM 18 mg/mL No activity [8]
B. subtilis ATCC 6633 Disc diffusion method Inhibition zone Control (8 mm) 1000–2000 μg/mL 0–12.5 mm [21]
B. subtilis ATCC 6633 Broth inhibition method % Inhibition None 1000–2000 μg/mL 5.1–97.9% [21]
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Strains Bioassay Results expresion Positive control Active concentration Main results Reference
B. subtilis ATCC 6633 Broth dilution assay MIC None No information No activity [22]
B. subtilis KCTC 1021 Disc diffusion method Inhibition zone Control (8 mm) 500–2000 μg/mL 8.5–12.5 mm [23]
B. subtilis KCTC 1021 Broth dilution % Inhibition None 1000–2000 μg/mL 5.1–97.9% [23]
B. subtilis VKM 1053 Agar diffusion method Inhibition zone 6–10 μM 0.8–1.2 μM [5]
B. cereus NCTC 7464 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
B. pumilus (wildtype hand
isolate)
Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
B. subtilis NCTC 10400
(NCIMB 8054)
Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
C. albicans Disc diffusion method Inhibition zone No information No information No activity [24]
C. albicans Broth dilution assay MIC Tetracyclin 100 μg/mL (68%) 50 mg/mL 0–70% [4]
C. albicans Disc diffusion method Inhibition zone Tetracyclin 100 μg/mL
(20 mm)
50 mg/mL 14–20 mm [4]
C. albicans ATCC 10231 Paper disc diffusion method Inhibition zone Chloramphenicol 30 mcg
(27 mm)
50 μL/disc No activity [25]
C. albicans ATCC 10231 Agar diffusion method Inhibition zone Anfotericin (0.2 mm) 200 μg/mL >200 μg/mL [26]
C. albicans ATCC 18804 Broth dilution assay MIC Anfotericin B (0.0004 μM) No information 0.039 μM [13]
C. albicans ATCC 90028 Agar well diffusion Anfotericin B (100 μg/disc) 40 μg 3.0 mm [27]
C. albicans UPCC 2168 Agar well diffusion Inhibition zone,
antimicotic index
Canesten (18 mm, 0.3) 30 μg 12 mm, 0.2 [9]
C. glabrata ATCC 2001 Agar diffusion method Inhibition zone Anfotericin (0.4 mm) 200 μg/mL >200 μg/mL [26]
C. gloesporoides Broth dilution assay IC50, MIC,
Morphological
changes
15 μM >15 μM; >15 μM;- [10]
C. jejuni Broth dilution assay Adhesion,
cytotoxicity,
Antibacterial
3-sialyllactose (IC50 1.4 mg/
mL)
500 mg/mL IC50 < 3 mg/mL,
<10%, no activity
[28]
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C. jejuni NCTC 11168
(ATCC 700819)
Broth dilution assay MIC, IC50, %
Inhibition
Ampicillin (IC50 1.61 μg/mL) 15 μM No activity [29]
C. lagenarium Direct inoculation Rates of Inhibition Control untreated leaves No information 1.90 [30}
C. lagenarium Direct inoculation Rates of Inhibition Control untreated leaves No information 12.80 [30]
C. neoformans ATCC 32608 Broth dilution assay MIC Anfotericin B (0.0008 μM) No information 0.039 μM [13]
C. parapsilepsis ATCC
22019
Agar diffusion method Inhibition zone Anfotericin (0.4 mm) 200 μg/mL >200 μg/mL [26]
C. sativus (S. Ito and
Kurib.)
Paper disc diffusion method Inhibition zone Mancozeb, Thiram, Carboxin,
Benomyl (1 mg/disc)
5 mg/disc weak activity, not
indicated
[31]
C. tropicalis ATCC 750 Agar diffusion method Inhibition zone Anfotericin (0.4 mm) 200 μg/mL 2.0 mm [26]
C. utilis ATCC 22023 Agar diffusion method Inhibition zone Anfotericin (0.4 mm) 200 μg/mL >200 μg/mL [26]
C. violaceum ATCC 12472 Quorum sensing Inhibition zone None No information 7 mm [32]
C. violaceum ATCC 31532 Quorum sensing Inhibition zone None No information No activity [33]
C. violaceum NTCT 13274 Quorum sensing Inhibition zone None No information No activity [33]
C. albicans Disk diffusion method Inhibition zone Ciprofloxacin (5 μg/disc) 130–200 mg/mL >200 mg/mL [12]
C. glabrata ATCC 2001 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
C. krusei ATCC 6258 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
C. parapsilosis ATCC 22019 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
C. michiganense subesp.
Michiganense Ac-1144
Agar diffusion method Inhibition zone 6–10 μM 0.8–1.4 [5]
Cupriavidus sp. Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
E. coccus ATCC 13048 Agar diffusion method Inhibition zone, MIC Erythromicin 1.0 μM 19 mg/mL No activity [8]
E. coli Disc diffusion, broth
dilution
Inhibition zone, MIC Erythromicin (MIC 27 μg/mL) 10–500 μg/mL 13.3 mm, MIC
50 μg/mL
[34]
E. coli Agar inoculation MIC None No information 1.0 mg/mL [17]
E. coli Agar diffusion method Inhibition zone None 0.1–1.0 mg/mL >0.5 mg/mL
(1–4 mm)
[35]
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E. coli Agar diffusion method Inhibition zone Cloramphenicol 10 mg/mL
(30.5 mm)
50–200 mg/mL 5.25–23.5 mm [36]
E. coli Diet CFU count Control No information Inhibition [8]
E. coli Disc diffusion method Inhibition zone None 1 g/mL 10.2–18.5 mm [37]
E. coli Disc diffusion method Inhibition zone None No information 13.21 mm [18]
E. coli Disc diffusion method Inhibition zone Gentamycin 10 μg/disc
(18.9 mm)
10 mg/mL 12.05–14.21 mm [19]
E. coli Broth dilution MIC Gentamycin (MIC 1.25 μg/
mL)
10 μg/mL 250–500 μg/mL [19]
E. coli Disc diffusion method Inhibition zone No information No information 11–13 mm [24]
E. coli Agar well diffusion Inhibition zone None 120 μg/mL 2.0–3.0 mm [20]
E. coli Broth dilution assay MIC Tetracyclin 100 μg/mL (78%) 50 mg/mL 14–62% [4]
E. coli Disc diffusion method Inhibition zone Tetracyclin 100 μg/mL
(18 mm)
50 mg/mL 12–15 mm [4]
E. coli 7075 Agar diffusion method Inhibition zone Gentamicyn 1 mg/disc,
Tetracyclin 2 mg/disc
4–12 μg/disc No activity [16]
E. coli 8739 Agar diffusion method Inhibition zone None 1 mg/mL >1 mg/mL [38]
E. coli ATCC 11229 Disc diffusion method Inhibition zone Control (8 mm) 500–2000 μg/mL 11–13.5 mm [21]
E. coli ATCC 11229 Broth inhibition method % Inhibition None 500–2000 μg/mL 98.1–100% [21]
E. coli ATCC 1229 Broth dilution assay MIC None No information No activity [22]
E. coli ATCC 15224 Agar diffusion method Inhibition zone, MIC Erythromicin 1.0 μM 20 mg/mL No activity [8]
E. coli ATCC 25322 Agar well diffusion Inhibition zone Gentamycin 240 mg/mL 6.5 mm [39]
E. coli ATCC 8677 Paper disc diffusion method Inhibition zone Ticarcillin 75 mcg (27 mm) 50 μL/disc No activity [26]
E. coli ATCC 8739 Broth dilution assay MIC None S, S/2 Inhibition [40]
E. coli DSM 1103 Broth dilution assay MIC None 2 mg/mL No activity [14]
E. coli DSM 1103 Microtiterd method MIC None 2 mg/mL No activity [15]
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E. coli KCTC 2441 Disc diffusion method Inhibition zone Control (8 mm) 500–2000 μg/mL 9.0–12 mm [23]
E. coli KCTC 2441 Broth dilution % Inhibition None 1500–2000 μg/mL 13–98.4% [23]
E. coli NCTC 25922 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
E. coli NCTC 9001 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
E. coli UPCC 1195 Agar well diffusion Inhibition zone,
antimicotic index
Chloramphenicol (25 mm,
3.2)
30 μg 11 mm, 0.1 [9]
E. faecalis Irrigation in situ None 7 mg/mL weak activity, not
indicated
[41]
E. faecalis ATCC 19433 Agar diffusion method Inhibition zone, MIC Erythromicin 1.0 μM.
Cefixime 1.0 μM
21 mg/mL No activity [8]
E. coli 0157 NCTC 12900 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
E. coli DH5 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
Enterobacter/Klebsiella sp. Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
E. faecalis NCTC 775 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
Exophiala (Wangiella)
dermatitidis QC 7895
Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
F. avenaceum Broth dilution assay IC50, MIC,
Morphological
changes
15 μM 13.1 μM; 6.7 μM; + [10]
F. graminearum VKM F-
1668
Broth dilution assay IC50 (50% growth
inhibition)
6–10 μM >10 μM [5]
F. oxysporium Schlecht Paper disc diffusion method Inhibition zone Mancozeb, Thiram, Carboxin,
Benomyl (1 mg/disc)
6 μM 5.7 μM [31]
F. oxysporium TSKHA-4 Broth dilution assay IC50 (50% growth
inhibiton)
Kanamycin 6 μM 5.7 μM [5]
F. oxysporium TSKHA-4 Microtiterd method IC53 None 15.6–250 μg/mL No activity [11]
H. pylori Paper disc diffusion method Inhibition zone Control (8 mm) No information 10 mm [42]
H. pylori NCTC 11639
(ATCC 43629)
Broth dilution assay MIC, IC50, %
Inhibition
Gentamicin
(IC50 0.081 μg/mL)
500 mg/mL 25% [29]
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K. pneumoniae Agar diffusion method Inhibition zone Gentamicyn 1 mg/disc,
Tetracyclin 2 mg/disc
4–12 μg/disc No activity [16]
K. pneumoniae Agar diffusion method Inhibition zone Cloramphenicol 10 mg/mL
(26.5 mm)
50–200 mg/mL — [36]
K. pneumoniae Disc diffusion method Inhibition zone Gentamycin 10 μg/disc
(18.9 mm)
10 mg/mL 13.24–17.72 mm [19]
K. pneumoniae Broth dilution MIC Gentamycin (MIC 5.0 μg/mL) 10 μg/mL 125–250 μg/mL [19]
K. pneumoniae ATCC
13866
Broth dilution assay MIC Cloramphenicol (0.001 μM) No information 0.625 μM [13]
K. pneumoniae UC 5 Agar diffusion method Inhibition zone, MIC Erythromicin 1.0 μM.
Cefixime 1.0 μM
22 mg/mL No activity [8]
K. aerogenes NCTC 9528 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
K. pneumoniae 700,603 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
L. monocytogenes KCCM
40307
Disc diffusion method.
Broth Inhibition method
Inhibition zone. %
Inhibition
Control (8 mm). None 500–2000 μg/mL 0–12 mm. 5.1–97.9% [21]
L. monocytogenes KCCM
40307
Disc diffusion method.
Broth Inhibition method
Inhibition zone. %
Inhibition
Control (8 mm). None 500–2000 μg/mL 10.5–12 mm.
27.2–94%
[23]
L. monocytogenes NCTC
11994
Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
M. aureum 4721 E Broth dilution MIC Streptomycin (IC50 1.14 μg/
mL)
500 μg/mL >500 μg/mL [41]
M. bovis BCG Broth dilution MIC Streptomycin (IC50 1.14 μg/
mL)
500 μg/mL >500 μg/mL [43]
M. canis Agar well diffusion, agar
tube dilution
No information No information No information Inhibition [44]
M. kristinae Agar inoculation MIC None No information 5.0–7.0 mg/mL [17]
M. laxa Microassay method on
slides
ICG, IGTE Only in vivo assays (Imazalil,
Fenhexamid)
0.75X 11%, 5% [7]
M. luteus Agar well diffusion Inhibition zone None 120 μg/mL 5.0–9.0 mm [20]
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M. luteus ATCC 10240 Agar diffusion method MIC Erythromicin 1.0 μM 23 mg/mL 1.0 μM [8]
M. piriformis Paper disc diffusion method % Inhibition None S, S/2, S/10, S/100 5.3–66.7% [6]
M. smegmatis MC2 155 Broth dilution MIC Streptomycin (IC50 1.14 μg/
mL)
120 μg/mL 5.3–66.7% [43]
M. tuberulosis H37RA Broth dilution method MIC Rifampim. Isoniazid.
Kanamycin
No information > 200 μg/mL [44]
MRSA (clinical isolated) Broth dilution assay.
Microtiterd method
MIC None 2 mg/mL 375 μg/mL. 500 μg/
mL
[14]
MRSA AARM 3696 Disc diffusion method Inhibition zone Gentamicin 0.2 mg/disc
(20.1 mm)
0.5–3.0 mg/disc 6.8–16.5 mm [45]
P. acnes Broth dilution assay No information No information No information No information [46]
P. aeruginosa Broth dilution assay No information No information No information No information [46]
P. aeruginosa Disc diffusion, broth
dilution
Inhibition zone, MIC Erythromicin 10–500 μg/mL No activity [34]
P. aeruginosa Agar diffusion method Inhibition zone Gentamicyn 1 mg/disc,
Tetracyclin 2 mg/disc
4–12 μg/disc No activity [16]
P. aeruginosa Agar diffusion method Inhibition zone Cloramphenicol 10 mg/mL
(26.0 mm)
50–200 mg/mL — [36]
P. aeruginosa Disc diffusion method Inhibition zone Gentamycin 10 μg/disc
(20.0 mm)
10 mg/mL 16.52–19.19 mm [19]
P. aeruginosa Broth dilution MIC Gentamycin (MIC 2.5 μg/mL) 10 μg/mL 125–250 μg/mL [19]
P. aeruginosa Agar well diffusion Inhibition zone None 120 μg/mL 8.0–13.0 mm [20]
P. aeruginosa ATCC 15442 Broth dilution assay MIC Cloramphenicol (0.015 μM) No information 2.5 μM [13]
P. aeruginosa ATCC 7221 Agar diffusion method Inhibition zone, MIC Erythromicin 1.0 μM.
Cefixime 1.0 μM
24 mg/mL No activity [8]
P. aeruginosa ATCC 9027 Broth dilution assay MIC None No information No activity [22]
P. aeruginosa ATCC 9721 Paper disc diffusion method Inhibition zone Ticarcillin 75 mcg (20 mm) 50 μL/disc No activity [25]
P. aeruginosa UPCC 1244 Agar well diffusion Inhibition zone,
antimicotic index
Chloramphenicol (23 mm,
2.8)
30 μg 11 mm, 0.1 [9]
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P. betae Broth dilution assay IC50, MIC,
Morphological
changes
15 μM 10.7 μM; 8.0 μM; + [10]
P. betae F-2532 Microtiterd method IC54 None 15.6–250 μg/mL No activity [11]
P. debaryanum VKM F-
1505
Broth dilution assay IC50 (50% growth
inhibition)
None 6–10 μM 2.6 μM [5]
P. digitatum (Perss) Sacc Microassay method on
slides
ICG, IGTE Only in vivo assays (Imazalil,
Fenhexamid)
0.75X 12%, 42% [7]
P. expansum Paper disc diffusion method % Inhibition None S, S/2, S/10, S/100 15.7–69.7% [6]
P. expansum Link. Microassay method on
slides
ICG, IGTE Only in vivo assays (Imazalil,
Fenhexamid)
0.75X No activity [7]
P. expansum Link. ATCC
42710
Paper disc diffusion method Inhibition zone Control (8 mm) 0.1 g/mL 12 mm [47]
P. infestans Microtiterd method IC55 None 15.6–250 μg/mL No activity [11]
P. infestans OSV 12 Direct inoculation (potato
disc)
Disease development None 1.3–5.3 μM 1.3–5.2 μM [5]
P. italicum Wehmer Microassay method on
slides
ICG, IGTE Only in vivo assays (Imazalil,
Fenhexamid)
0.75X 2%, 56% [7]
P. mirabilis Agar diffusion method Inhibition zone Gentamicyn 1 mg/disc,
Tetracyclin 2 mg/disc
4–12 μg/disc No activity [16]
P. mirabilis Agar diffusion method Inhibition zone None 0.1–1.0 mg/mL >0.5 mg/mL
(4–10 mm)
[35]
P. ovale Broth dilution assay No information No information No information No information [46]
P. syringeae VKM B-1546 Agar diffusion method Inhibition zone 6–10 μM 1.2–1.3 μM [5]
P. vulgaris Disc diffusion, broth
dilution
Inhibition zone, MIC Erythromicin (MIC 26 μg/mL) 10–500 μg/mL 10.1 mm, MIC
100 μg/mL
[34]
P. vulgaris Agar inoculation MIC None No information 5.0 mg/mL [17]
P. vulgaris Disc diffusion method Inhibition zone Gentamycin 10 μg/disc
(19.5 mm)
10 mg/mL 13.38–18.33 mm [19]
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P. vulgaris Broth dilution MIC Gentamycin (MIC 2.5 μg/mL) 10 μg/mL 250–500 μg/mL [19]
Penicillium sp. QC 743275 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
Pseudomona sp. Disc diffusion method Inhibition zone No information No information 11–21 mm [24]
P. aeruginosa NCTC 1662 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
P. aeruginosa NCTC 27853 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
Pseudomonas sp. Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
R. solani 18,619 Agar tube dilution Inhibition growth Terbinafine 12 mg/mL 100% 25 mg/mL 77.47% [8]
R. solani Kühn Paper disc diffusion method Inhibition zone Mancozeb, Thiram, Carboxin,
Benomyl (1 mg/disc)
5 mg/disc 4.75–17.63 mm [31]
S. aureus NCTC 8178 Microtiterd method MIC None 2 mg/mL 500 μg/mL [15]
S. abony enterica NCTC
6017
Broth dilution assay MIC None S, S/2 Inhibition [40]
S. agalactiae Disc diffusion method Inhibition zone None 1 g/mL 11.1–19.7 mm [37]
S. aureus Broth dilution assay No information No information No information No information [46]
S. aureus Disc diffusion, broth
dilution
Inhibition zone, MIC Erythromicin (MIC 33 μg/mL) 10–500 μg/mL 12.7 mm, MIC
50 μg/mL
[34]
S. aureus Agar diffusion method Inhibition zone Gentamicyn 1 mg/disc,
Tetracyclin 2 mg/disc
4–12 μg/disc No activity [16}
S. aureus Agar inoculation MIC None No information 5.0 mg/mL [17]
S. aureus Agar diffusion method Inhibition zone None 0.1–1.0 mg/mL >0.5 mg/mL
(1–4 mm)
[35]
S. aureus Agar diffusion method Inhibition zone Cloramphenicol 10 mg/mL
(35.0 mm)
100–200 mg/mL 9.0–10.75 mm [36]
S. aureus Disc diffusion method Inhibition zone None 1 g/mL 9.7–19.9 mm [37]
S. aureus Disc diffusion method Inhibition zone None No information 16.15 mm [18]
S. aureus Disc diffusion method Inhibition zone Tetracyclin 10 μg/disc
(38.8 mm)
10 mg/mL 11.22–15.07 mm [19]
S. aureus Broth dilution MIC Tetracyclin (MIC 2.5 μg/mL) 10 μg/mL 250 μg/mL [19]
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S. aureus Disc diffusion method Inhibition zone No information No information 11–21 mm [24]
S. aureus Agar well diffusion, agar
tube dilution
No information No information No information Inhibition [44]
S. aureus Agar well diffusion Inhibition zone None 120 μg/mL 4.0–11.0 mm [20]
S. aureus Broth dilution assay MIC Tetracyclin 100 μg/mL (75%) 50 mg/mL 0–76% [4]
S. aureus Disc diffusion method Inhibition zone Tetracyclin 100 μg/mL
(17 mm)
50 mg/mL 9–18 mm [4]
S. aureus (salted white
cheese)
Agar diffusion method Inhibition zone Cephalotin 30 μg/mL (24 mm) 10 mg/mL 16 mm [9]
S. aureus ATCC 12600 Paper disc diffusion method Inhibition zone Chloramphenicol 30 mcg
(27 mm)
50 μl/disc No activity [25]
S. aureus ATCC 25922 Agar well diffusion Inhibition zone Penicillin 320 mg/mL 10.4 mm [39]
S. aureus ATCC 43300 Disc diffusion method Inhibition zone Erythromycin 50 μg/well 40 μg 7.5 mm [27]
S. aureus ATCC 6530 Broth dilution assay MIC None No information No activity [22]
S. aureus ATCC 6538 Broth dilution assay MIC Cloramphenicol (0.063 μM) No information 5.0 μM [13]
S. aureus ATCC 6538 Broth dilution assay MIC None S, S/2 No activity [40]
S. aureus ATCC 6538 Agar diffusion method Inhibition zone, MIC Erythromicin 1.0 μM.
Cefixime 1.0 μM
26 mg/mL No activity [8]
S. aureus ATCC 6538 Disc diffusion method Inhibition zone Control (8 mm) 1500–2000 μg/mL 0–12 mm [22]
S. aureus ATCC 6538 Broth inhibition method % Inhibition None 1500–2000 μg/mL 5.1–97.9% [22]
S. aureus ATCC 6538 Agar diffusion method Inhibition zone None 1 mg/mL >1 mg/mL [38]
S. aureus KCTC 1916 Disc diffussion method Inhibition zone Control (8 mm) 500–2000 μg/mL 8.5–13.5 mm [24]
S. aureus KCTC 1916 Broth dilution % Inhibition None 500–2000 μg/mL 98.1–100% [24]
S. aureus KCTC 3881 Disc diffussion method Inhibition zone Gentamicin 0.2 mg/disc
(20.1 mm)
0.5–3.0 mg/disc 6.8–16.5 mm [45]
S. aureus NCTC 8178 Broth dilution assay MIC None 2 mg/mL 375 μg/mL [14]
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Strains Bioassay Results expresion Positive control Active concentration Main results Reference
S. aureus UPCC 1143 Agar well diffussion Inhibition zone,
antimicotic index
Chloramphenicol (20 mm,
2.3)
30 μg No activity [9]
S. australis Broth dilution assay Growth None 10–10,000 ppm No activity [46]
S. cerviseae Broth dilution assay MIC Tetracyclin 100 μg/mL (50%) 50 mg/mL 0–64% [4]
S. cerviseae Disc diffussion method Inhibition zone Tetracyclin 100 μg/mL
18 mm)
50 mg/mL 12–15 mm [4]
S. dysgalactiae Disc diffusion method Inhibition zone None 1 g/mL 13.8–9.6 mm [37]
S. enterica sorovar
typhimurium ATCC 13311
Broth dilution assay MIC Cloramphenicol (0.001 μM) No information 5.0 μM [13]
S. enteriditis Disc diffussion method Inhibition zone No information No information No activity [24]
S. epidermis KCTC 1917 Disc diffussion method Inhibition zone Gentamicin 0.2 mg/disc
(24.4 mm)
130–200 mg/mL 7.3–16.7 mm [45]
S. fiexneri Disc diffusion, broth
dilution
Inhibition zone, MIC Erythromicin 10–500 μg/mL No activity [34]
S. haemolyticus Agar diffusion method Inhibition zone Gentamicyn 1 mg/disc,
Tetracyclin 2 mg/disc
4–12 μg/disc Weak activity, not
indicated
[16]
S. marscens Agar inoculation MIC None No information 1.0–5.0 mg/mL [17]
S. sonnei ATCC 11060 Broth dilution assay MIC Cloramphenicol (0.001 μM) No information 2.5 μM [13]
S. tiphimurium SARB 69 Broth dilution assay MIC None 2 mg/mL No activity [14]
S. typhi Agar well diffussion, agar
tube dilution
No information No information No information Inhibition [44]
S. typhi (food poisoning
patients)
Agar diffusion method Inhibition zone Cephalotin 30 μg/mL (18 mm) 10 mg/mL 14 mm [9]
S. typhi H. Agar diffusion method Inhibition zone Gentamicyn 1 mg/disc,
Tetracyclin 2 mg/disc
4–12 μg/disc No activity [16]
S. typhimurium Reference
collection B-69
Microtiterd method MIC None 2 mg/mL No activity [15]
Salmonella poona NCTC
4840
Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
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Strains Bioassay Results expresion Positive control Active concentration Main results Reference
Scedosporium apiospermum
QC 7870
Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
Serratia marcescens Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
Serratia/Rahnella sp. Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
Staphylococcus Diet CFU count Control No information Inhibition [8]
S. aureus (MRSA) 43,300 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
S. aureus (MSSA) 25,923 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
S. aureus NCTC 6571 Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
Staphylococcus epidermidis
NCTC 14990
Disk diffusion method Inhibition zone Ciprofloxacin 5 μg/disc 130–200 mg/mL >200 mg/mL [12]
T. longifusus Agar well diffusion, agar
tube dilution
No information No information No information Inhibition [45]
T. mentagrophytes UPCC
4193
Agar well diffusion Inhibition zone,
antimicotic index
Canesten (55 mm, 4.3) 30 μg 12 mm, 0.2 [9]
V. albo-atrum Broth dilution assay IC50, MIC,
Morphological
changes
None 15 μM >15 μM; >15 μM;  [10]
V. albo-atrum F-2437 Microtiterd method IC56 None 15.6–250 μg/mL No activity [11]
V. cholera ATCC 11623 Agar diffusion method MIC Erythromicin 1.0 μM.
Cefixime 1.0 μM
27 mg/mL 12.5 μM [8]
V. parahaemolyticus KCTC
2471
Disc diffusion method.
Broth Inhibition method
Inhibition zone. %
Inhibition
Control (8 mm). None. 500–2000 μg/mL 9.5–15 mm.
5.1–97.9%
[21]
V. parahaemolyticus KCTC
2471
Disc diffusion method.
Broth dilution.
Inhibition zone. %
Inhibition
Control (8 mm). None. 500–2000 μg/mL 9.5 - 15 mm.
84.0–97%
[23]
X. campestris VKM 608 Broth dilution assay IC50 (50% growth
inhibition)
6–10 μM 1.0–1.2 μM [5]
Table 1. Principal types of bioassays carried out to determine the antimicrobial activity of the genus Taraxacum and their respective results.
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used as a preliminary check for antibacterial activity prior to more detailed studies. In the agar
well test diffusion method, the extract is deposited into wells cut into the agar and can be used
as a screening method when large numbers of extracts or large numbers of bacterial isolates
are to be screened. In the agar dilution method, a known concentration of the extract is mixed
with the agar prior to strain inoculation. In some cases, the inoculated plates or tubes are
exposed to UV light to screen the presence of light-sensitizing photochemicals. In the broth
dilution method, different techniques exist for determining the end-point, such as an optical
density measurement or the enumeration of colonies by viable count. Antimicrobial activity
can also be analyzed by a spore germination assay in broth or on glass slides. In situ antifungal
activity can be achieved by electron microscopy techniques such as scanning and transmission,
as well as by confocal laser scanning microscopy [2].
Direct tissue inoculation is the least used testing method, probably due to the inherent charac-
teristics of the substrate (fruits, vegetables, etc.) that can affect the final results and the stan-
dardized laboratory conditions needed for proper result comparisons. Authors also indicate
certain restrictions regarding the use of a specific technique. For instance, diffusion techniques
seem to be inadequate for non-polar extracts, although many reports with these techniques
have been published. Furthermore, when only a small amount of sample is available, diffusion
techniques can be considered more appropriate [3]. The disc diffusion method is quick and
easy but has several serious shortcomings, such as false positives and negative results due to
poor test substance solubility and diffusion through the semi-solid nutritive medium [1].
The agar diffusion and microdilution broth methods are the two most common techniques for
determining the antimicrobial activities of Taraxacum extracts, but the results are not always
reproducible; factors, such as the volume and concentration of the extract placed on the paper
disc and the solvent used, vary considerably between studies. When results are compared, the
different sensitivities of the assays make antimicrobial activity highly dependent on the selec-
tion of the proper test. For example, aqueous fractions of T. officinale showed no activity in the
disc diffusion test but moderate toxicity against E. coli and B. subtilis in the broth dilution test
[4]. Considering this issue, a list of the bioassays used for testing Taraxacum extracts against
every strain identified, including the main results, is presented in Table 1.
2. Taraxacum extracts versus commercial antibiotics
When comparing Taraxacum extracts to commercial antibiotics, C. jejuni adhesion was con-
trolled by a Taraxacum extract with an IC50 value of 2.7 mg/mL, slightly less compared to the
3.4 mg/mL obtained with 30-sialyllactose [28]. In another study, a T. officinale extract showed
MIC values of 0.004 mg/mL, similar to chloramphenicol with MIC values of 0.001–0.06 mg/mL
but considerably lower than amphotericin B with MIC values of 0.4 –0.8 μg/mL for different
Gram positive and Gram negative bacteria, respectively [13]. The MIC value of 1.0 mg/mL for
M. luteus was similar for a methanolic extract and for erythromycin and cefixime, but consid-
erably lower than the MIC value of 12.5 mg/mL obtained for V. cholera [8]. In the same work,
the inhibition percentage for Aspergillus spp. and Rhizoctonia spp. was 37–84%, relatively lower
than terbinafine at 12 mg/mL and 100% inhibition.
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Generally, researchers select only one technique for evaluating the antimicrobial perfor-
mance of Taraxacum. Few studies have assessed agar disc diffusion and broth dilution in
parallel, even when the limitations and advantages for both bioassays have been already
stated, as indicated above. An example of this includes the antibacterial properties of an
ethanolic extract of the T. mongolicum flower, whose fractions were examined by both bio-
assays [19]. The authors indicated that at 0.1 mg/disc, inhibition results were relatively lower
for the plant extract compared to gentamicin and tetracycline, with values between 7.12 and
19.4 mm for the plant extracts and 18.9–38.8 mm for the antibiotics. However, MIC values of
0.06–0.5 mg/mL were obtained for plant extracts against the tested strains. Antibiotics had
much lower MIC values of 3.0–5.0 μg/mL, which reaffirms the fact that different bioassays
need to be performed in parallel to accurately evaluate the antimicrobial effectiveness of an
extract.
The weak activity that some authors have indicated could be improved by higher concen-
trations, which are needed to reach quantifiable antimicrobial activity under different
conditions and assays. For instance, concentrations of T. officinale extracts at 130–500 mg/
mL were needed to achieve the effect of amphotericin B at 0.2–0.4 μg/mL against Candida
strains [26]. In the cases of mancozeb, carboxin, thiram, and benomyl, only 1 mg/disc
was effective in inhibiting the growth of R. solani, F. oxysporum, and C. sativus, while the
Taraxacum extract needed a concentration of 5 mg/disc to achieve the same effect [31]. For
H. pylori and C. jejuni, growth was inhibited by ampicillin and gentamicin at concentrations
of 0.5–5.0 μg/mL, while an extract of 500 mg/mL was needed to achieve this inhibition [29].
Considering the disc assay method, an extract of ethyl acetate at 10 mg/mL showed minor
inhibition zones (14–18 mm) against A. hydrophila, S. typhi, S. aureus, B. cereus, and E. coli as
compared to cephalothin at 0.03 mg/mL (18–24 mm) [9]. In this study, inhibition diameters
were only 20–25% smaller than those reached by the synthetic antibiotic, but the extract
concentration was more than 300 times higher, as well as 100 times higher than what would
normally be indicated for an attractive natural antibiotic in a commercial setting. In a
similar study, the inhibition zones of chloramphenicol at 0.02 mg/mL (10.7–23.5 mm)
against E. coli and S. aureus were lower compared to an ethanolic extract of T. officinale at
200 mg/mL (25–30 mm) [36]. In this case, the extract showed higher activity but its concen-
tration was 10,000 times higher than its respective antibiotic. Moreover, methanolic extracts
of T. officinale at 50 mg/mL resulted in inhibition similar to tetracycline at 0.1 mg/mL using
broth dilution and disc assay methods against E. coli, S. aureus, and B. subtilis, among
others; that is, a concentration 500 times greater than the antibiotic was necessary to obtain
a similar effect [4].
In several studies, different Taraxacum extracts exhibited no activity under the tested condi-
tions. For instance, embedded discs with 50 μL of an ethanolic extract of T. officinale were not
active compared to controls, such as ticarcillin, at 75 μg/disc, and chloramphenicol, at 30 μg/
disc [26]. Another study, using a similar extract at 2.5 mg/disc, was inactive against certain
strains, as compared to gentamycin, at 1.0 mg/disc, and tetracycline, at 2.0 mg/disc [16].
Different extracts of T. officinale leaves and roots (chloroform, methanol, and water) were not
active towards Mycobacterium compared to streptomycin at 1.14 μg/mL [43]. An ethanolic
extract of T. phaleratum was also inactive against the same strain compared to rifampin at
0.005–0.01 μg/mL, isoniazid at 0.05–0.1 μg/mL, and kanamycin at 2.5–5.0 μg/mL [44]. A leaf
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and root extract of T. officinale at 150–200 mg/mL was inactive against 24 bacterial strains, but
ciprofloxacin at 5.0 μg/disc showed high antimicrobial activity [12].
The conclusion of these studies may be misleading if slight dilutions or excessively high
concentrations are tested. For example, experiments with quantities higher than 1.0 mg/mL
for extracts or 0.1 mg/mL for isolated pure compounds should be avoided, whereas the
presence of activity is very interesting when concentrations are below 0.1 μg/mL for extracts,
and 0.01 mg/mL for isolated compounds [1]. Even when promising results have been achieved,
the extracts have also shown contradictory results and can mislead the actual potential of this
plant extract if no further investigation is pursued.
In general, active concentrations of Taraxacum extracts that achieve inhibitions similar to the
synthetic antibiotics are 100–10,000 times higher, which makes Taraxacum extracts unsuitable for
pharmaceutical development at the moment. However, this is expected since synthetic antibi-
otics are pure, concentrated compounds, whereas plant extracts are a mixture of different, dilute
compounds that act synergistically or antagonistically. Because this situation is common and a
characteristic of plant extracts, some authors indicate the possibility of using antibiotics syner-
gistically with plant extracts to improve the action mechanisms against antibiotic-resistant bac-
teria. No research regarding the synergistic use of Taraxacum genus has yet been performed [47].
At present, only commercial and synthetic antibiotics, such as kanamycin, amphotericin B,
terbinafine, chloramphenicol, and cephalothin, among others, have been considered as posi-
tive controls for establishing strain sensitivity. Comparisons of Taraxacum with natural, com-
mercially available antibiotic compounds (such as propolis and other honey products) have
been neglected: only one study, regarding antibacterial agents for dental care, contains a
comparison with propolis [41]. The comparison with natural antibiotics, for example, honey,
might be more realistic in traditional medicine due to the similar vegetable origin and charac-
teristics. As long as no pure compound extraction or purification of Taraxacum extracts can be
performed reliably for testing antimicrobial activity, the real potential of the Taraxacum genus
as a source of natural therapeutic agents cannot be established.
Alternatively, instead of only utilizing a chemical antibiotic or a natural antibiotic, antimicro-
bial synergistic interactions between plant bioactives and some common antibiotics have been
reported. There are many advantages to using antimicrobial compounds from medicinal
plants, such as fewer side effects, better patient tolerance, lower expense, acceptance due to
long history of use, and renewability [48].
3. Expression of results in antimicrobial studies
Regarding the expression of the results, the minimum inhibitory concentration (MIC), mini-
mum bactericidal concentration (MBC), and inhibition percentage of growth are cited by
researchers as the most common measurements of antimicrobial performance. In this sense,
there are two primary categories for measuring an antimicrobial agent: bactericidal or bacteri-
ostatic. Bacteriostatic refers to an agent that prevents the growth of bacteria and a bactericidal
agent kills bacteria, but a complete separation of these definitions might be further pursued.
This difference only applies under strict laboratory conditions and is inconsistent for a
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particular agent against all bacteria; indeed, it can be influenced by growth conditions, bacte-
rial density, test duration, and extent of reduction in bacterial numbers. Furthermore, bacteri-
ostatic activity has been defined as an MBC/MIC ratio of 4, but numerous technical problems
and other factors can affect the determination of that ratio and may have an important impact
on the interpretation of the in vivo situation. Although MBC and MIC data may provide
information on the potential action of antibacterial agents in vitro, it is necessary to combine
this information with pharmacokinetic and -dynamic data to provide more meaningful pre-
dictions of efficacy in vivo [49]. Considering this information, no pharmacokinetic or -dynamic
studies have been conducted involving the Taraxacum genus to date. The majority of the
research (not only as an antimicrobial agent, but also as an important medicinal plant) has
been performed from a traditional perspective, based on centuries of oral traditions. Only in
recent decades has Taraxacum been subjected to a considerable amount of tests, principally due
to its anti-inflammatory and anti-carcinogenic properties [50]. The antimicrobial properties of
this genus have been widely known, but only very general studies have been performed to
date, with information that is difficult to interconnect as the action mechanisms and the
specific compounds involved have not yet been elucidated. Nevertheless, all the data gathered
here provides a promising case for the advantageous commercial usage of this genus.
Considering this general approach, most of the research regarding Taraxacum indicates MIC
values and inhibition percentages measured in relation to area (in solid cultures) or optical
density (in broth cultures). The MBC values were not identified in the consulted references. An
observation was made that the MIC definition sometimes differed between publications, another
obstacle for data comparison. Some MIC definitions are: “the lowest concentration of the tested
products that inhibited the development of microorganisms” [40]; “the lowest concentration
required to show a marked inhibition of mycobacterial growth at 72 h” [43]; “the lowest concen-
tration of the compound to inhibit the growth of microorganisms” [19]; and “the lowest sample
concentration at which no pink color appeared” [15]. This indicates that MIC values are relative
to each study and is compounded by the fact that the complete procedure (including extraction
process and sample manipulation) is not standardized and varies considerably among the
authors. Furthermore, due to the different solubilities and stabilities of the various compounds
in the solvent and the sensitivity of the antimicrobial activity assay performed, directly compar-
ing MIC values is difficult and sometimes confusing. As further examples, in three different
studies, the authors reported MIC values in the 0.05–5.0 mg range for ethanol, methanol, or
water extracts against S. aureus using broth microdilution or agar diffusion method as bioassays
[13, 17, 34]. This meant that only MIC values could be used as a comparison against the positive
control under the same conditions and may only be considered as an initial screening for further
antimicrobial approaches; it cannot provide a reliable comparison between studies. The MIC/
MBC ratio might be an option for making antimicrobial activity more independent of assay
conditions if similar extraction conditions and sample manipulation have been performed.
4. Scaling up from in vitro to in vivo assays
Scaling up an antimicrobial assay from controlled, in vitro conditions to that of natural, in vivo
conditions can be difficult if no proper considerations are taken. For instance, active concentrations
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for in vitro conditions frequently cannot be reached in vivo because the infecting microorganisms
are never exposed to constant concentrations of an antimicrobial agent. Microorganisms in vivo are
subject to competition from other microorganisms present in the tissue, so decreased microbial
activity might be due to this competition rather than directly related to the antimicrobial activity of
the plant extract. Moreover, temperature, pH, and humidity are more difficult to control in an
in vivo system. Another issue to consider is that microorganisms in a microtiter plate are in the
form of a suspension, whereas bacteria associated with different illnesses naturally form biofilms
(organ and tissue infections, dental plaque, etc.), representing an extra challenge for antimicrobial
agents [1]. Until now, only studies regarding fruit and vegetable infections have shown a parallel
between in vitro and in vivo responses to Taraxacum extracts (Chapter 1; see Section 2.2.2), but
studies in animal tissues and organs have not yet been performed directly.
5. Factors affecting antimicrobial activity of extracts
The following sections are referred and discussed in accordance with the information provided
in Table 2 (see Chapter 1) and Figure 1. It should be noted that the impact of the parameters
mentioned in these sections, except for solvent selection, on the antimicrobial properties of the
Taraxacum genus has not yet been studied.
5.1. Plant material collection
Scientific criteria should be used in the selection of the sample material. To avoid the use of
random criteria, the selection of plants should be made from an ethnopharmacological
perspective. All the species tested need to be perfectly described and identified, including
location, season, date, and time of day harvested. The use of commercial samples should be
limited to cases of standardized extracts or defined phytomedicines [3]. The phytochemical
composition of Taraxacum (and plants in general) is known to depend on the season in which
Taraxacum parts mentioned in the text Number of extracts tested Positive antimicrobial
activity
Negative
antimicrobial
activity
Root 51 17 11% 34 43%
Leaves 38 28 18% 10 13%
Flower 13 10 7% 3 4%
Honey 6 4 3% 2 3%
Herb 3 3 2% 0 0%
Aerial 32 24 16% 8 10%
Whole plant 8 0 0% 8 10%
No information 81 66 43% 15 19%
Total 232 152 80
Table 2. Summary of the antimicrobial results regarding Taraxacum plant parts tested in main studies.
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it is collected, as well as other ecological and climate factors. For example, sesquiterpene
lactones are noticeable in the roots, particularly when harvested in the spring [51]. Sterols,
which are present in the leaves throughout the year, are highest during the winter months,
whereas levels of sitosterol and cycloartenol esters are highest during periods of sunshine
[52]. Few authors indicated in which period of the year the plant was harvested, collected,
purchased, or the collection site, another factor that could influence the final concentration of
compounds in the extract, even when the same extraction conditions are applied. No
Taraxacum studies have investigated a possible relationship between harvesting time or
collecting site and its antimicrobial properties. Only one study indicated the environmental
conditions in which the plant was grown and collected before the antimicrobial assay [27].
5.2. Species identification
Generally, there is a lack of taxonomic identification of the species characterized, mentioned
occasionally as Taraxi radix, Taraxi folium, Taraxi herba, Taraxacum spp., or dandelion, especially
when researchers use commercial preparations or purchase the plant from local markets [29,
33, 46]. Samples are commonly obtained in the wild, but the lack of proper identification
makes the comparison for antimicrobial properties imprecise for determining the actual effi-
cacy of Taraxacum extracts; therefore, only partial conclusions can be pursued and not always
extrapolated. For instance, dandelion is used as a common name for several species: khur
mang, a name for dandelion in Tibet, can be used for T. officinale, T. mongolicum, T. tibetanum,
and T. Sikkimense [53]. As previously stated, environmental conditions affect the tissue compo-
sition of the plants, but few reports indicate the corresponding information for further
Figure 1. Reported extraction conditions to achieve positive antimicrobial results.
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consultation. The importance of proper identification also relates to the risk of toxicity between
morphologically similar, but chemically distinct, plants, which is a potential health risk for the
communities that harvest medicinal plants in the wild. Only a small portion of the research
available mentions proper, expert identification.
5.3. Plant part utilization
Reports indicate that compounds present in Taraxacum vary within parts of the plant, and
even though there are common compounds across sections, these concentrations vary as well
[54, 55]. A disadvantage that creates further uncertainties when comparing data is that a
considerable amount of studies do not indicate which part of the plant was used. In general,
aerial parts (leaves, flowers, and seeds), roots, and whole Taraxacum plants have been used in
antimicrobial research. Only one Taraxacum study indicated differences between a root
extract and a leaf extract, in which the root extract was active against S. aureus and S. typhi.
Extracts of plant roots and herbs of different Taraxacum species endemic to Turkey displayed
significant activity against M. canis and T. longifusus [44]. Few studies refer to the antimicro-
bial properties of Taraxacum derivatives. Pseudomona sp., S. aureus, and E. coli were inhibited
in a disc diffusion assay, but C. albicans and S. enteriditis were not inhibited by T. officinale
honey [24]. The pH of dandelion honey is considered the probable antibacterial component
observed against S. aureus [56]. Analyzing the information gathered in this work (also see
Table 2), Taraxacum root extracts are less effective at fungal and bacterial inhibition than the
aerial parts and seem to be more effective on Gram positive than Gram negative bacteria.
5.4. Sample manipulation
Several authors propose that plants need to be dried and chopped before extraction. This is a
consensus among researches due to the necessity of storing samples prior to processing;
however, it is a central issue when testing biological activities because bioactive compounds
are highly sensitive and react quickly to changes in environmental conditions. These types of
changes are common: a sample is stored at room temperature, refrigerated, frozen, or freeze-
dried. In rare cases, further sample manipulation has been reported prior to extraction. Specif-
ically, the removal of lipids and proteins with solvents [31] could also affect the compound
profile of the extract and the final antimicrobial activity. In one study, a fresh sample was also
homogenized before tested [30]. In our research, sample manipulation seems to be just as
adequate whether plant parts are dried under the sun or by oven prior to extraction, or used
directly as fresh biomass in extract preparation. Due to the possibility that the material used in
the extraction may be contaminated, a white control is considered in the activity bioassays,
which is the sample not inoculated with the pathogen, to confirm sterility of the stored sample.
5.5. Extraction procedure
Traditional extraction techniques involve solid-liquid extraction with or without high tempera-
tures (maceration, soaking, reflux, etc.), and are characterized by the use of high solvent volumes
and long extraction times. These techniques often produce low bioactive extraction yields, low
selectivity, and reproducibility can sometimes be compromised. In a common extraction proce-
dure, plant parts are soaked in solvent for extended periods, the slurry is filtered, the filtrate may
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be centrifuged multiple times for clarification, and the result may be dried under reduced
pressure and re-dissolved in alcohol to a determined concentration. Solid-liquid extractions
using soaking, maceration, and homogenization are the most used for Taraxacum (although, to a
lesser extent, the Soxhlet procedure has been used). Pressurized liquid extraction, subcritical
water extraction, and supercritical fluid extraction are presented as novel techniques with impor-
tant advantages over traditional solvent extraction, such as rapidity, higher yields, and reduced
solvent usage. Microwave-assisted extraction and ultrasonic-assisted extraction are pretreat-
ments that can improve the extraction yield by releasing the compounds from the solid matrix
[2]. No studies using these techniques have been conducted for the extraction of antibacterial
compounds from Taraxacum because maceration, blending, and boiling are the most common
extraction procedures for this genus. In one study, the sample was sonically treated prior to
extraction but no conclusion regarding the effectiveness of this pretreatment can be pursued [22].
5.6. Relationship between temperature and extraction time
Temperature directly influences both the solubility equilibrium and mass transfer rate of an
extraction process. When temperature is increased, the lower viscosity and surface tension of
the solvent improves its diffusion inside the solid matrix, achieving a higher yield and extrac-
tion rate along with enhanced diffusivity and solubilization results. The primary disadvan-
tages of applying a higher temperature are increased solvent boil-off and reduced effective
contact area between solid and liquid phases. A high temperature can also decrease the cell
barrier by weakening the integrity of the cell wall and membrane. Furthermore, bioactive
compounds may decompose at high temperatures, which require research on the influence of
temperature on the overall yield. Temperatures ranging from cold (4C), room temperature
(20–25C), and solvent boiling point (50–100C) have been reported for Taraxacum. The major-
ity of the work was conducted in the range of 20–40C, where the maceration process was
proposed and, to a lesser extent, extraction under boiling temperatures has also been indicated
(80–100C, depending on the solvent). Our findings suggest that inhibitory activity is most
probable when using a maceration process at mild temperatures (Chapter 1; See Table 2).
Determination of the duration of the extraction process required to extract the bioactive com-
pounds, that is, the minimum time at which equilibrium of solvent concentration between inner
and outer cells is reached, is important. Most bioactive compounds are sensitive to elevated
temperatures and are susceptible to thermal decomposition outside of the original matrix. The
extraction time mentioned in literature for Taraxacum ranged from 5min for homogenization, 1–3
hours for boiling, and up to 3 weeks for maceration. A clear relationship between extraction time
and antimicrobial activity was not observed in the data presented. However, it is possible that
the antimicrobial compounds extracted are relatively stable when extracted by maceration at
mild temperatures because numerous positive results regarding inhibitory activity were
obtained with this process that included times ranging from 4 hours to 5 days.
5.7. Relationship between sample size, solid to solvent ratio, and agitation speed
The particle size of the plant material influences the extraction rate by affecting the total mass
transfer area per unit volume, which increases as particle size is reduced. Several authors
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Herbal Medicine
294
Polarity index 9.0 8.2 7.7 7.4 6.3 6.3 6.2 6.0 5.9 5.6 5.5 5.4 5.1 5.1 4.4 4.1 4.0 3.1 0.0
Genus/solvent
W
a
t
e
r
E
t
h
a
n
o
l
2
0
%
E
t
h
a
n
o
l
3
5
%
E
t
h
a
n
o
l
4
0
–

4
5
%
E
t
h
a
n
o
l
7
0
–
7
5
%
M
e
t
h
a
n
o
l
7
0
%
A
c
e
t
i
c
a
c
i
d
E
t
h
a
n
o
l
8
0
%
M
e
t
h
a
n
o
l
8
0
%
E
t
h
a
n
o
l
9
0
%
M
e
t
h
a
n
o
l
9
0
%
E
t
h
a
n
o
l
9
6
–
1
0
0
%
M
e
t
h
a
n
o
l
1
0
0
%
A
c
e
t
o
n
e
E
t
h
y
l
a
c
e
t
a
t
e
C
h
l
o
r
o
f
o
r
m
D
i
e
t
y
l
e
t
h
e
r
8
0
%
D
i
c
h
l
o
r
o
m
e
t
h
a
n
e
H
e
x
a
n
e
Serratia — +
Shigella — +
Staphylococcus /+ — — + + /+ — /+ /+ + + + /+ —
Trichophyton + +
Vibrio — +
Xanthomonas +
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chopped and ground Taraxacum plant material, but few indicate the mesh grain utilized in
extract powder selection. Bioactive compounds are dissolved from the solid matrix into the
solvent by a physical process under mass transfer principles and compound solubility. When
the amount of extraction solvent is increased, the possibility of the bioactive compounds in the
solid matrix coming into contact increases. However, the removal of solute from the solvent
requires energy. Therefore, if more solvent than needed is used, there will be a higher energy
consumption, needlessly increasing processing costs. In the literature reviewed for Taraxacum,
the sample:solvent ratio ranged between 1:1 and 1:40 w/v. In light of the gathered data, this
range has no direct impact on antimicrobial activity but certainly affects the economy of the
process. Interestingly, most of the positive results have been achieved with ratios of 1:10–1:4.
A higher agitation speed in solid-liquid extraction is preferred, in accordance with mass transfer
theory. In this process, the solute moves from inside the solid to the surface through diffusion or
capillary action. Once the compound is on the surface, it is recovered by the solvent through
convective mass transfer. Agitation rate affects the mass transfer coefficient (kL) and, at higher
rates, improves the convective mass transfer rate, which facilitates the extraction process and
leads to increases in extraction yields. For Taraxacum, the agitation speed is not usually men-
tioned in homogenization processes but the most cited value is 170 rpm. Similarly, for the solid:
solvent ratio, no direct impact was found in comparisons of different studies.
5.8. Solvents
One critical parameter in extraction procedures is the solvent used for sequestering bioactives
from the plant matrix. Extractants that solubilize antimicrobial compounds from plants have
been ranked by factors such as biohazard risk and ease of solvent removal from fractions.
Methanol was ranked second to methylene dichloride and superior to ethanol and water. Even
though acetone was rated the highest, it is one of the least used solvents for bioactive extrac-
tion. Ethanol and methanol, in contrast, are both commonly used for initial extraction yet may
not demonstrate the greatest sensitivity in yielding antimicrobial chemicals on an initial
screening [57]. Solvents used for the extraction of bioactive compounds from plants are
selected according to polarity and the compounds they are capable of solubilizing. Different
solvents may modify results. Apolar solvents (cyclohexane, hexane, toluene, benzene, ether,
chloroform, and ethyl acetate) primarily solubilize alkaloids, terpenoids, coumarins, fatty
acids, flavonoids, and terpenoids; polar solvents (acetone, acetonitrile, butanol, propanol,
ethanol, methanol, and water) primarily extract flavonols, lectins, alkaloids, quassinoids, fla-
vones, polyphenols, tannins, and saponins [58].
The impact of solvent selection is recognized as extremely critical. For example, the gathered
data indicate that growth inhibition on fungal strains can be reached by using ethanolic extracts
but not aqueous extracts. Moreover, in the same study, inhibition of Gram positive and Gram
negative bacteria using an aqueous extract was indicated but no inhibition was achieved using
an acetone extract against the same strains [17]. However, it has also been reported that water
extracts led to better activity than ethanolic extracts against acne strains, which can be useful in
the skin care field [46]. Alcohol extracts tend to display better activity against bacteria and fungi
than water extracts, the latter being generally ineffective. Crude Taraxacum extracts are com-
monly used in testing antifungal and antibacterial properties [57], but only a few reports involve
the fractioning of the crude sample with other solvents to concentrate and isolate potential
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compounds related to microbial activity [4, 15, 19, 22, 24, 42]. These authors agree that antimi-
crobial activity decreases as follows: ethyl acetate > dichloromethane ≈ chloroform > butanol ≈
hexane > water. This indicates that the antimicrobial compounds should be extracted according
to the solvent polarities, showing effective extractions from solvents with a polarity index
ranging from approximately 3.0 to 7.0 instead of too polar or apolar solvents. Data analysis
indicates that solvents with low (0–3.0) and high (6.1–9.0) polarities are less active against
microorganisms than medium polarity solvents (3.1–6.0). A list of the solvents used in research
regarding Taraxacum antimicrobial activity is presented in Tables 3 and 4.
6. Perspectives of potential bioassays
As stated above, reports have shown that the antimicrobial potential of different compounds
depends not only on the chemical composition of the extract, but also on the targeted microor-
ganism. Further evaluation of the activity of these plants required the study of different
conditions. Different parts of the plant (flowers, leaves, stems, etc.), solvent selection (water,
alcohol, and organic solvents), extraction procedure (temperature, pH, time, and equipment),
bioassay selection (diffusion, dilution, bioautographic methods), and bioassay conditions (vol-
ume of inoculum, growth phase, culture medium used, pH of the media, incubation time, and
temperature) among others, complicate the comparison of published data.
Studies of the identification and characterization of Taraxacum compounds are generally
unrelated to a particular pharmacological property. Therefore, the extraction methods for
identifying and quantifying extract compounds differ in sample manipulation:temperature,
extraction time, and solvent (among others parameters), indicating that comparisons of the
extraction methods utilized in antimicrobial activity assays are typically invalid. This compli-
cates the establishment of a relationship between compounds isolated from Taraxacum parts
and antimicrobial activities.
Nevertheless, Taraxacum has been proven effective against most known strains of bacteria, fungi,
and protozoa that attack animals and plants through an in vitro or in vivo approach. All studies of
Taraxacum extracts against microbes that cause important human diseases (E. coli, S. aureus, and
A. niger, among others) were conducted in vitro, while microbes causing foodborne diseases with
economic implications (C. lagenarium for cucumber or S. australis for salmonids) were also tested
in vivo. For humans, only antimicrobial in vitro assays were conducted primarily due to the
ethical issues of clinical trials. Several authors have mentioned that Taraxacum, despite being
used as a well-known medicinal plant for centuries, suffers from a lack of in vivo evidence and
Solvents used in Taraxacum
extracts
Number of extracts tested Positive antimicrobial
activity
Negative antimicrobial
activity
Low polarity (0–3.0) 47 22 9% 25 10%
Medium polarity (3.1–6.0) 100 70 28% 30 12%
High polarity (6.1–9.0) 101 38 15% 63 25%
Total 248 130 118
Table 4. Summary of the antimicrobial results regarding the polarity of the Taraxacum extracts tested in main studies.
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clinical trials supporting its use [58], which prevents this genus from attracting the possibility of
economic development in the pharmacological industry.
Depending on the bioassay selected, diverse extraction conditions should be tested to study
the influence of solvents, temperatures, and other parameters that might change outcomes in
the extraction process employed. Authors often use non-standardized procedures derived
from self-experience combined with bibliographic references, further complicating compari-
sons between investigations. Even though there are vast amounts of literature on Taraxacum
biochemical composition and antimicrobial activity, few isolated compounds can be directly
related to this activity because studies do not always identify the accurate active fraction and
its associated components. In bioassays, the extract generally used is a mixture of compounds;
therefore, there is a strong possibility that the activity may be due to the synergy of the
compounds present in the extract and not related to a specific compound. The identification,
extraction, and isolation of these active compounds are major areas of research that can be
initially pursued to formulate a promising source of Taraxacum antibiotics. The next step is to
test these extracts on in vitro and in vivo systems to establish pharmacodynamics and interac-
tions, facilitating the commercial attractiveness of Taraxacum to the pharmaceutical industry.
The bioavailability, pharmacodynamics, and action mechanisms in Taraxacum bioactives have
not yet been addressed. Considering that primarily in vitro and, to a much lesser extent, in vivo
studies have been conducted using Taraxacum extracts, direct application is the only route that
has been considered. If a bioactive compound is going to be suggested as a potential therapeutic
agent, other application routes must be tested. Oral ingestion, injection, or inhalation have
different characteristics that need to be considered, such as flavor, compound volatility, stability
in stomach pH, and possible organ irritation, among others. Therefore, clinical trials are funda-
mental to evaluating the suitability of Taraxacum extract use in pharmacological approaches.
7. Conclusion
Only a minor fraction of the Taraxacum species has been tested against microorganisms that
cause human, animal, and plant diseases. Considering that species can differ in composition
due to environmental and genetic characteristics, the evaluated antimicrobial properties could
also differ, which means that there is a considerable potential in establishing this genus as a
commercial antimicrobial compound. Currently, this genus is considered to have a mild anti-
microbial activity compared to other plants, but its worldwide presence and simple cultivation
provide an advantage that needs to be assessed more accurately.
Generally, studies do not provide sufficient details concerning the sample manipulation, extrac-
tion procedure, or bioassay used, which are necessary for standardization and further statistical
comparison. Therefore, despite the published data, it is not possible to conclude which solvent or
which conditions provide the optimal results for antimicrobial activity; however, it is possible to
set a range of operational parameters that can be used to maximize extract potential.
Isolation and purification of Taraxacum compounds needs to be further explored. Although
synergy is an important characteristic of plant mixtures responsible for its antimicrobial activ-
ity and even though bioactive synthesis is difficult and expensive on a large scale, knowing the
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nature of Taraxacum extracts and the associated antimicrobial mechanisms may provide impor-
tant advantages in synthesizing specific structures with improved antimicrobial properties.
Contradictory information is available in the data analyzed; however, these discrepancies are
probably the result of different procedures, particular considerations, or inaccurate process
descriptions. These differences make it quite possible that the results are not directly related to
the full antimicrobial potential of Taraxacum but to a limited scope. Therefore, extracts and
bioassays must be conducted under a standardized protocol to provide reproducible studies
and reliable data comparisons between published articles, which would empower research
conducted by authors worldwide and allow for the interrelated study of this genus. In addi-
tion, the efficacy of reported biological activity in vitro could be validated with in vivo assays.
Standardization of the entire procedure (sample manipulation, extraction, and further bioas-
say) is necessary for comparisons of published data and establishing the exact potential of
Taraxacum, or any other plant extract, as a commercial antimicrobial agent. The uniformity of
an extract is highly susceptible to external factors that influence plant metabolism. This prob-
lem could be solved by performing plant breeding techniques with selected Taraxacum species
grown under controlled environmental conditions.
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